News
Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...
President Donald Trump is expected to sign an executive order allowing for the inclusion of private market investments in ...
20m
Zacks Small Cap Research on MSNLGVN Continues to Expand Heart Treatment Options
LGVN READ THE FULL LGVN RESEARCH REPORT Longeveron (NASDAQ:LGVN) is a company that should be getting more attention from investors for the treatments that could be coming to market in the near future.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results